Jitosita 50 Tablet (10 Tab)

Medicine Information

Jitosita 50 Tablet Overview:

Jitosita 50 Tablet is an oral anti-hyperglycemic medication used to manage blood sugar levels in adults with Type 2 Diabetes Mellitus.

It is prescribed when dietary changes, regular exercise, and other single-agent medications is not enough to maintain adequate blood glucose levels.

Type 2 diabetes occurs when the body either does not produce enough insulin or cannot use it effectively, leading to chronically high blood glucose. If left unmanaged, this can result in serious long-term complications, including heart disease, kidney dysfunction, nerve damage, vision loss, and impaired wound healing.

It contains Sitagliptin, as its active ingredient, which works by increasing the levels of natural substances called incretins. It helps the pancreas release more insulin and signals the liver to produce less glucose (especially after meals) and effectively controls blood sugar without causing significant weight gain.

It is important to note that Jitosita 50 Tablet is not for treating Type 1 diabetes or diabetic ketoacidosis.

 

Composition:

Each film coated tablet contains- Sitagliptin Phosphate Monohydrate eq. to Sitagliptin: 50 mg and Excipients q.s.

Colours: Titanium Dioxide, Yellow Oxide of Iron & Red Oxide of Iron

 

Uses & Benefits of Jitosita 50 Tablet:

Jitosita 50 Tablet is specifically indicated for lowering blood glucose levels in adults with Type 2 Diabetes Mellitus, also known as non-insulin-dependent diabetes mellitus (NIDDM).

It is prescribed as an adjunct to diet and exercise to help patients achieve better glycemic control. By maintaining stable blood sugar levels, this medication plays a vital role in preventing the long-term, serious complications associated with diabetes, such as kidney damage, vision loss (blindness), nerve dysfunction, and the risk of limb amputation.

Additionally, because it works naturally with the body's insulin response, it helps manage sugar levels without typically causing significant weight gain.

 

How Does Jitosita 50 Tablet Work:

Jitosita 50 Tablet contains Sitagliptin, which belongs to a class of medications known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This antihyperglycemic agent works by regulating the insulin and glucose levels in the body through a specialized hormonal pathway.

The medication functions by preventing the breakdown of natural hormones known as incretins (like GLP-1). Usually, an enzyme called DPP-4 quickly degrades these hormones; however, Sitagliptin blocks this enzyme, allowing incretins to stay active longer. These hormones are generally released throughout the day, especially after meals, to signal the pancreas to produce more insulin and prompt the liver to lower its glucose production. By extending the action of these incretins, Alsita 100 helps the body respond more effectively to fluctuations in blood sugar, leading to more stable and consistent glucose regulation.

 

Dosage of Jitosita 50 Tablet:

• Usage Direction

Take Jitosita 50 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Jitosita 50 Tablet should be swallowed whole with water and not to be crushed, or chewed, preferably at the same time each day. Do not stop or alter the dose of Jitosita 50 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you are unsure about the administration procedures of Alsita 100, consult with your doctor or pharmacist.

• Missed Dose

If you miss a dose of Jitosita 50 Tablet, take it as soon as you remember on the same day. But, if it is almost time for your next scheduled dose, skip the one you missed and continue following your regular dosing schedule. Do not attempt to take two doses if you have forgotten one. If you often forget to take your medication, consult with your doctor to re-evaluate your dosing schedule. Frequently missing doses could lead to undesired outcomes.

You can set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

• Overdose

If you accidentally take more than the prescribed dose of Jitosita 50 Tablet, contact a physician or local poison control center immediately, even if there are no visible symptoms. Symptoms of overdose may include severe hypoglycemia (very low blood sugar).

 

Contraindications of Jitosita 50 Tablet:

Do not take Jitosita 50 Tablet if you are allergic to Sitagliptin, or any of the other ingredients in the medicine. Signs of an allergic reaction may include skin rash, itching, hives, breathing difficulty, or swelling of the face, lips, tongue, or throat.

Additionally, this medication is not recommended for people with type 1 diabetes mellitus and diabetic ketoacidosis. The safety and efficacy of Jitosita 50 Tablet have not been established in children and adolescents, and therefore it should not be used in individuals under 18 years of age.

 

Precautions & Warnings of Jitosita 50 Tablet:

Before taking Jitosita 50 Tablet, inform your doctor if you have any medical history, particularly any history of pancreatitis, gallstones, or high triglycerides. Patients must carefully monitor for the symptoms of acute pancreatitis, such as persistent, severe abdominal pain; if this occurs, stop the medication immediately and seek medical help. Additionally, before taking Jitosita 50 Tablet, it is mandatory to assess your kidney function, as dosage adjustments are required if you have moderate to severe renal impairment.

You should also monitor for signs of heart failure, such as unusual shortness of breath, rapid weight gain, or swelling in the hands, feet, and ankles.

While Jitosita 50 Tablet generally carries a low risk of low blood sugar (hypoglycemia) when used alone, the risk increases significantly if taken with insulin or sulfonylureas.

Furthermore, exercise caution in patients with Type 1 diabetes or diabetic ketoacidosis (DKA). If you experience symptoms like nausea, vomiting, confusion, or breathing difficulties, consult your doctor immediately, as these may indicate serious complications that require urgent intervention.

 

Side Effects of Jitosita 50 Tablet:

While Jitosita 50 Tablet is generally well-tolerated, some patients may experience mild side effects as the body adapts to the medication. Common side effects frequently reported include upper respiratory tract infections, a sore throat, or a stuffy nose. Some individuals may also experience headaches, stomach discomfort, diarrhea, or localized pain in the arms or legs. These symptoms are often temporary and may resolve as treatment continues.

However, some serious and rare side effects require immediate medical attention. Although Sitagliptin has a low risk of causing low blood sugar (hypoglycemia) on its own, the risk increases when it is used in combination with insulin or sulfonylureas. Patients should also be alert for severe joint pain, muscle aches, or signs of kidney problems. Other rare but serious conditions associated with this class of medication include dizziness, interstitial lung disease, and bullous pemphigoid,a skin condition characterized by large, fluid-filled blisters. If you experience any of these severe symptoms, or signs of a serious allergic reaction, consult your healthcare provider immediately.

 

Safety Related Concerns of Jitosita 50 Tablet:

• Pregnancy

Jitosita 50 Tablet is not recommended during pregnancy, unless clearly necessary and prescribed by a doctor. Limited data exists on use in pregnant women. If you are pregnant or planning to become pregnant, talk to your doctor before taking this medication to weigh the benefits against potential risks to the developing baby. In many cases, healthcare providers may recommend switching to safer treatments, such as insulin, to maintain proper blood sugar control.

• Breastfeeding

It is better to avoid the use of the Jitosita 50 Tablet while breastfeeding, since it is unknown whether the ingredients could pass into the breast milk and affect the breastfed child. Therefore, consulting with your doctor before taking Jitosita 50 Tablet is crucial.

• Alcohol

Avoid excessive alcohol consumption, while taking Jitosita 50 Tablet as it can increase the risk of pancreatitis and cause unpredictable fluctuations in blood sugar.

If you choose to drink alcohol, do so in moderation, never on an empty stomach, and monitor your blood sugar more frequently.

• Food Interactions

Jitosita 50 Tablet can be taken with or without food, as prescribed by your healthcare professional. There are no specific food interactions. Maintaining a consistent diabetic diet is essential to regulate blood glucose levels, which can be achieved by avoiding sugary items, high-fat foods, and limiting carbohydrates, as these are primarily responsible for glucose spikes.

• Drug Interactions

Jitosita 50 Tablet can interact with various medications, either by changing their effectiveness or increasing the risk of toxicity. It is crucial to inform your healthcare provider if you are taking other anti-diabetic medications, such as insulin, or sulfonylureas, as this may increase the risk of low blood sugar, and dose adjustments may be necessary.

Additionally, clinical monitoring is recommended if you are taking Digoxin, a medication used for heart conditions, as Sitagliptin may slightly increase the concentration of Digoxin in the blood.

Always inform your healthcare provider and pharmacist about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, minerals, and herbal supplements, to avoid potential interactions.

• Using Machinery & Driving

Using Jitosita 50 Tablet may affect your ability to drive or operate machinery, especially when taken with other antidiabetic medicines such as insulin or sulphonylureas. These combinations can cause low blood sugar (hypoglycemia), which may lead to symptoms like blurred vision, dizziness, shaking, sweating, or confusion.

It is important to recognize early signs of low blood sugar and avoid driving or risky activities if you feel unwell or dizzy. Always carry a quick source of glucose, such as fruit juice or sugar tablets, and monitor your blood sugar regularly during treatment.

 

Storage of Jitosita 50 Tablet:

Store protected from light and moisture, at a temperature below 30°C. Keep the medicine out of reach of children.

Avoid using it after the expiry date, printed on the packaging. Dispose of expired or unused medication properly; do not throw it away casually.

 

 

Helpful Tips:

• To enhance the effectiveness of Jitosita 50 Tablet, follow fiber rich diabetic diet under medical supervision. Increase intake of whole grains and leafy greens to slow sugar absorption.
• Aim for at least 30 minutes of moderate activity daily to improve insulin sensitivity.
• Keep a log of your blood glucose levels to share with your healthcare provider.
• Make sure to have quick sugar supplies on hand for low blood sugar episodes.
• Do not suddenly stop your medication unless your doctor specifically tells you to.
• Do not share your medicine with someone else having the same symptoms as you, as the drug requires a prescription.

 

 

Frequently Asked Questions (FAQs):

 

Q. Why is Jitosita 50 Tablet used?

A. Jitosita 50 Tablet is primarily used to manage and lower high blood sugar levels (hyperglycemia) in adults with Type 2 Diabetes Mellitus. It is typically prescribed as an add-on treatment when diet, regular exercise, and other single-agent medications are not enough to keep blood glucose within a healthy range. Controlling blood sugar helps reduce the risk of serious long-term health complications such as kidney damage and heart disease.

 

Q. How long does it take for Jitosita 50 Tablet to work?

A. Jitosita 50 Tablet starts working within a few hours of the first dose, specifically helping to manage blood sugar spikes that occur after meals. However, it may take several weeks of consistent use to see the full impact on your HbA1c levels, which represent your long-term blood sugar over the past two to three months.

To ensure maximum effectiveness, it is essential to follow the exact dosage and schedule prescribed by your physician. The time frame for noticeable improvement can vary based on an individual’s current health status, lifestyle, and how their body responds to the medication.

 

Q. Can I stop taking Jitosita 50 Tablet once my sugar levels are normal?

A. No, you should not stop taking Jitosita 50 Tablet without consulting your doctor first. Diabetes is a chronic condition, and the medication helps keep your sugar levels stable. Discontinuing treatment abruptly can cause your blood glucose to spike, increasing the risk of long-term complications.

 

Q. Does Jitosita 50 Tablet cause hypoglycemia (low blood sugar)?

A. When used alone, Alsita 100 has a very low risk of causing hypoglycemia. However, the risk increases significantly if you are also taking other diabetes medications like insulin or glimepiride. Be sure to recognize the signs of low blood sugar, such as sweating, shaking, and dizziness. If these symptoms occur, stop taking the medicine and seek immediate medical advice.

 

Q. Is it safe to take Jitosita 50 Tablet for patients with kidney problems?

A. It can be used in patients with kidney issues, but since the medicine is cleared from the body through the kidneys, your doctor may need to adjust the dose and prescribe a lower dose. Regular monitoring of kidney function through blood tests is usually required.

 

Q. Does Jitosita 50 Tablet cause weight gain?

A. No, one of the primary benefits of Sitagliptin (the active ingredient in Jitosita 50 Tablet) is that it is "weight neutral." Unlike some other diabetes medications, such as sulfonylureas or insulin, it does not typically cause weight gain and may even support weight management when combined with a proper diet.

 

 

Reference:

1. Sitagliptin 25 mg, 50 mg & 100 mg Film-coated Tablets. Package leaflet: Information for the patient. Last Revised: May 2022. Accessed on: 10th September 2026. Click Here

2. JANUVIA® (sitagliptin) Tablets. HIGHLIGHTS OF PRESCRIBING INFORMATION. Accessed on: 10th September 2026. Click Here

3. Sitapril Tablets (Sitagliptin Tablets USP 25 mg / 50mg / 100 mg). Patient Information Leaflet. Last Revised: Oct 30, 2020. Accessed on: 10th September 2026. Click Here

4. Januvia 25 mg, 50 mg & 100 mg film-coated tablets. SUMMARY OF PRODUCT CHARACTERISTICS. Accessed on: 10th September 2026. Click Here